Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga; Teresa Freire; Luis Ubillos

doi:10.1002/ijc.30246

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga
, Teresa Freire
, Luis Ubillos

Universidad de la República
Institut Pasteur de Montevideo

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

Idioma original	Inglés
Páginas (desde-hasta)	2144
Número de páginas	1
Publicación	International Journal of Cancer
Volumen	139
N.º	9
DOI	https://doi.org/10.1002/ijc.30246
Estado	Publicada - 1 nov. 2016
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1002/ijc.30246

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{5655f77e1d85414d90194a62952d5fd6,

title = "Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?",

author = "Eduardo Osinaga and Teresa Freire and Luis Ubillos",

year = "2016",

month = nov,

day = "1",

doi = "10.1002/ijc.30246",

language = "Ingl{\'e}s",

volume = "139",

pages = "2144",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer? / Osinaga, Eduardo; Freire, Teresa; Ubillos, Luis.
En: International Journal of Cancer, Vol. 139, N.º 9, 01.11.2016, p. 2144.

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

TY - JOUR

T1 - Author's reply to

T2 - Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

AU - Osinaga, Eduardo

AU - Freire, Teresa

AU - Ubillos, Luis

PY - 2016/11/1

Y1 - 2016/11/1

UR - https://www.scopus.com/pages/publications/84983042602

U2 - 10.1002/ijc.30246

DO - 10.1002/ijc.30246

M3 - Carta

C2 - 27352000

AN - SCOPUS:84983042602

SN - 0020-7136

VL - 139

SP - 2144

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 9

ER -